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Abstract
The cyanobacterial neurotoxin b-N-methylamino-L-alanine (BMAA) has been considered a serious health threat because of
its putative role in multiple neurodegenerative diseases. First reports on BMAA concentrations in cyanobacteria were
alarming: nearly all cyanobacteria were assumed to contain high BMAA concentrations, implying ubiquitous exposure.
Recent studies however question this presence of high BMAA concentrations in cyanobacteria. To assess the real risk of
BMAA to human health, this discrepancy must be resolved. We therefore tested whether the differences found could be
caused by the analytical methods used in different studies. Eight cyanobacterial samples and two control samples were
analyzed by three commonly used methods: HPLC-FLD analysis and LC-MS/MS analysis of both derivatized and
underivatized samples. In line with published results, HPLC-FLD detected relatively high BMAA concentrations in some
cyanobacterial samples, while both LC-MS/MS methods only detected BMAA in the positive control (cycad seed sarcotesta).
Because we could eliminate the use of different samples and treatments as causal factors, we demonstrate that the
observed differences were caused by the analytical methods. We conclude that HPLC-FLD overestimated BMAA
concentrations in some cyanobacterial samples due to its low selectivity and propose that BMAA might be present in
(some) cyanobacteria, but in the low mg/g or ng/g range instead of the high mg/g range as sometimes reported before. We
therefore recommend to use only selective and sensitive analytical methods like LC-MS/MS for BMAA analysis. Although
possibly present in low concentrations in cyanobacteria, BMAA can still form a health risk. Recent evidence on BMAA
accumulation in aquatic food chains suggests human exposure through consumption of fish and shellfish which expectedly
exceeds exposure through cyanobacteria.
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Introduction
The neurotoxic amino acid b-N-methylamino-L-alanine
(BMAA) has been linked to neurodegenerative diseases as
Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotro-
phic lateral sclerosis (ALS) [1]. BMAA was first identified in 1967
in the seeds of the cycad Cycas micronesica [2] in a survey on the
cause of the high incidence of ALS, PD and dementia on Guam
[3]. The possible etiological role of BMAA in this neurodegener-
ative disease was at first disputed [4], but was recently resurrected
by the discovery of high concentrations of BMAA in the protein
associated fraction of the cycad seeds and its biomagnification in
the Guamanian food chain [5–8]. Furthermore, the finding of
BMAA in the brains of people who had died with AD, ALS or PD
outside Guam pointed towards a wider occurrence of BMAA
[9,10]. The detection of BMAA in the cyanobacterium Nostoc sp.
that lives in symbiosis with the cycads [6] prompted the screening
of cyanobacteria from all over the world for BMAA [11–23].
First reports on BMAA concentrations in cyanobacteria were
alarming: high concentrations of BMAA were detected in nearly
all tested free living laboratory strains [11], field isolates [16], field
samples [13] and symbiotic species [11] (Table 1). In contrast, all
but one [21] later studies could not reproduce these first results;
BMAA was either not detected in cyanobacteria (e.g. [17,18]),
detected in some, yet not all, samples [23] or detected in all
samples, but at very low concentrations [14]. The suggestion that
BMAA might have been confused with its structural isomer a,c-
diaminobutyric acid (DAB) in the early studies [17] could be
refuted [24].
Nonetheless there is still little consensus on BMAA concentra-
tions in cyanobacteria. Cyanobacteria are ubiquitous and multiple
routes of human exposure to cyanobacteria and their toxins exist
[25]. It is therefore very important for human risk assessment to
find the cause of the discrepancy in published results on BMAA
concentrations in cyanobacteria.
Several factors underlie the different studies. Researchers have
used different samples, different sample treatments and different
analytical methods [24]. However, the differences in results seem
to be related to the analytical method used. High BMAA
concentrations and high percentages of positives samples were
found only in those studies that had used high performance liquid
chromatography with fluorescence detection (HPLC-FLD), gas
chromatography with mass spectrometry detection (GC-MS) or
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capillary electrophoresis (CE) for quantification (Table 1). On the
other hand, studies that had used high performance liquid
chromatography with tandem mass spectrometry detection (LC-
MS/MS) for quantification either did not detect BMAA, or
reported lower BMAA concentrations (Table 1). Therefore, we
hypothesized that different analytical methods for the determina-
tion of cyanobacterial BMAA deviate in their results. To test the
hypothesis, we analyzed a set of cyanobacterial and control
samples with three analytical methods: HPLC-FLD, LC-MS/MS
of derivatized samples and LC-MS/MS of underivatized samples.
The observed differences in our study were comparable to the
observed differences in literature and were caused by overestima-
tion of BMAA concentrations by HPLC-FLD.
Results
Method validation
Before sample analysis, all three methods were validated.
Results of method validation are shown in Table 2. LC-MS/MS
analysis of samples was performed with deuterium labeled BMAA
(D3BMAA) as an internal standard. However, the validation of
both LC-MS/MS methods was performed without correction for
the internal standard to make comparison with the HPLC-FLD
method possible. HPLC-FLD response was linear up to a
concentration of 1000 mg/l, while both LC-MS/MS responses
were linear up to 500 mg/l (Table 2). When corrected for the
response of D3BMAA however, the LC-MS/MS methods showed
a broader range of linearity (Figure S1). For all three methods, the
fit of the regression line was good (r2.0.999).
Detection and quantification limits of calibration standards were
within the same range for all three methods. For the LC-MS/MS
methods, the limit of detection (LOD) often equalled the limit of
quantification (LOQ). This is possible because for these methods,
LOD is defined as the lowest concentration where the signal-to-
noise (S/N) ratio of all product ions is at least 3:1 and the ratio of
the qualifier ion(s) to the quantifier ion is within a 20% relative
range. The conditions for the ratio of the qualifier ions to the
quantifier ion or for the S/N of the qualifier ions are often only
met at a S/N ratio of the quantifier ion of 10:1, in which case the
criteria for LOQ are also met. Chromatograms of LODs in
samples are shown in Figure S2. Detection limits in samples are
higher for both derivatized methods than for underivatized LC-
MS/MS analysis. This is due to the dilution during derivatization
(both extracts and hydrolyzed samples) and the extra dilution that
is needed in the hydrolyzed samples to ensure effective
derivatization [26,27]. A single LOD or LOQ of free BMAA in
samples could not be determined for the HPLC-FLD method. The
extracts of cyanobacterial samples showed many low peaks around
the retention time of BMAA, which made a good estimation of the
position of the baseline difficult. For each sample, the pattern of
these peaks was different, so no universal LOD or LOQ could be
derived. This problem did not occur in the hydrolyzed samples,
these chromatograms all showed fewer but higher peaks, with a
better definable baseline for BMAA. Because baseline variation
was higher for HPLC-FLD analysis than for LC-MS/MS analysis
of derivatized samples, detection and quantification limits of the
latter method in samples were lower. Underivatized LC-MS/MS
was the most sensitive method for analysis of both extracted and
hydrolyzed samples.
Interday and intraday precision was good for all three methods,
underivatized LC-MS/MS analysis was most precise. Inter
workup of hydrolyzed samples analyzed by HPLC-FLD showed
an unexplainable high variation. Retention times in HPLC-FLD
analysis were sensitive to variations in the buffer solution. This
resulted in retention time differences between runs of maximum
0.3 min. Within runs, retention times were stable (Table 2).
Of the samples that were spiked before extraction, between 83.6
and 86.8% of the expected signal was recovered. Samples that
were spiked before hydrolysis showed a lower recovery: between
46.7 (HPLC-FLD) and 69.3% (underivatized LC-MS/MS,
Table 3).
All three methods separated BMAA from its isomer DAB
(Figure 1).
BMAA in samples
Analysis of the same samples by the three methods yielded
different results (Table 4). Both LC-MS/MS methods only
indicated BMAA in the positive control, the sarcotesta of the
cycad seed. HPLC-FLD however indicated BMAA not only in the
cycad seed, but also in three of the eight cyanobacterial samples.
Of the three methods used, HPLC-FLD has the highest
detection limit for BMAA in samples. All BMAA concentrations
Table 1. Overview of studies that analyzed more than eight samples of free living cyanobacteria for BMAA.
Tested
samples
Fraction samples
positive for BMAA
BMAA concentration
in positive samplesa
Analytical
quantification method
Derivatization
method Reference
(n) (-) (mg/g DW)
8 1.00 402 (190–1110) CE None [21]
30 0.97 968 (10–6721) HPLC-FLD AccQH-Tag [11]
12 1.00 103 (8–287) HPLC-FLD AccQH-Tag [13]
27 0.96 129 (0.1–2757) GC-MS EZ:faastTM [16]
21 1.00 6.6*1023
(1*1023–15*1023)
LC-MS/MS AccQH-Tag [14]
20 0.95 1.35 (0.05–10.7) LC-MS EZ:faastTM [22]
21 0.42 13 (4–42) LC-MS/MS None [23]
36 0.00 - LC-MS/MS None [18]
30 0.00 - LC-MS/MS None [17]
aBMAA concentration is the sum of the free and protein associated concentrations. Values are averages, followed by minimum and maximum concentrations between
brackets.
doi:10.1371/journal.pone.0036667.t001
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as determined by HPLC-FLD were therefore far above the
detection limit of both LC-MS/MS methods (Tables 2 and 4). If
samples indeed contained BMAA concentrations as high as
indicated by HPLC-FLD, both LC-MS/MS methods should have
detected BMAA as well.
Free BMAA concentrations in the cycad seed sarcotesta were in
the same range for all three methods. Total BMAA was also
detected in the cycad seed by all three methods, but was below the
LOQ for HPLC-FLD (Table 4).
Discussion
We clearly showed that BMAA concentrations in some
cyanobacterial samples varied depending on the analytical method
used. The three methods only indicated similar BMAA concen-
trations in the positive control, the sarcotesta of a cycad seed. Since
we have used the same samples and employed identical sample
treatments, sample origin and treatment could be eliminated as
possible causal factors [24] of the observed differences. The
differences in BMAA concentrations can therefore only be
attributed to the analytical methods, and are roughly in line with
the observed discrepancy in published results (Table 1).
HPLC-FLD identified BMAA in three out of eight cyanobac-
terial samples, while both LC-MS/MS methods did not detect any
BMAA in cyanobacteria. These differences are most likely due to
the low selectivity of the HPLC-FLD. HPLC-FLD is less selective
than both LC-MS/MS methods, it has only two selection criteria:
retention time and fluorescence signal. Because BMAA does not
have fluorescent properties, derivatization with the fluorescent
AccQH-Tag was necessary for detection by HPLC-FLD. Both
retention time and fluorescence signal are properties of the
derivative of an analyte, instead of the analyte itself and any
compound that reacts with the AccQH-Tag gives the same
fluorescence signal after derivatization. The AccQH-Tag reacts
with primary and secondary amino groups [28,29], which means
that it reacts with all amino acids and other amino group
containing compounds. There are hundreds of naturally occurring
amino acids [30], so there is always a chance that a derivatized
compound other than BMAA has the same or similar retention
time as the BMAA derivative. If such a compound is present in a
sample, it leads to misidentification and subsequent overestimation
Table 2. Validation results of the three used methods, both LC-MS/MS methods are validated without correction for the internal
standard D3BMAA.
HPLC-FLD
LC-MS/MS
derivatized
LC-MS/MS
underivatized
Linearitya
Lowest concentration mg/l 15 5 7.5
Highest concentration mg/l 1000 500 500
Number of concentrations in
tested range
- 6 8 9
r2 - 0.999 0.999 0.999
Detection and quantification
limits
LOD calibration standard fmole/injection 68 85 106
LOQ calibration standard fmole/injection 102 85 317
LOD sample extract mg/g * 1.0 0.4
LOD sample hydrolyzed mg/g 40 10.0 1.6
LOQ sample extract mg/g * 1.0 0.4
LOQ sample hydrolyzed mg/g 120 10.0 1.6
Precision
Intraday precision (n = 6),
response
Relative SD (%) 2.8 3.0 0.7
Intraday precision (n = 6), RT Relative SD (%) 0.0 0.1 0.1
Interday precision (n = 12),
response
Relative SD (%) 4.6 5.0 1.9
Interday precision (n = 12), RT Relative SD (%) 0.1 0.0 0.2
Inter workup (n = 12) extract,
response
Relative SD (%) 8.6 6.7 7.1
Inter workup (n = 12) extract, RT Relative SD (%) 0.1 0.0 0.4
Inter workup (n = 12)
hydrolyzed, response
Relative SD (%) 17.0 10.6b 6.1
Inter workup (n = 12)
hydrolyzed, RT
Relative SD (%) 0.1 0.1b 0.1
LOD: limit of detection, LOQ: limit of quantification, RT: retention time,
aeach concentration is injected in triplicate,
bn = 11,
*not determined (see text).
doi:10.1371/journal.pone.0036667.t002
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of BMAA concentrations in that sample. HPLC-FLD is therefore
an uncertain method for amino acid analysis in complex biological
matrices that contain non-protein amino acids or other com-
pounds with an amino group [29], especially when the analyte is
present in low concentrations.
LC-MS/MS is a more selective method than HPLC-FLD
because it has four selection criteria: retention time, mass-to-
charge ratio (m/z) of the precursor ion (the charged ‘original’
molecule), m/z of the product ions after collision induced
dissociation and the ratio between the abundance of the product
ions. The chance of compound misidentification by LC-MS/MS is
therefore much smaller than by HPLC-FLD. In our study, LC-
MS/MS peaks were only identified as BMAA when all four
criteria were met.
The discrepancy in the results could not be caused by other
factors like method sensitivity or difference in sample treatment
(derivatization versus underivatized analysis). In our study, the
least sensitive method (HPLC-FLD) gave more positive results
than the more sensitive LC-MS/MS methods. Quantification by
LC-MS/MS was reliable because we used D3BMAA as an internal
standard in all samples [18], resulting in unbiased estimates of
BMAA concentrations in samples, also in low concentrations
(Figure S3). The observed differences in results can therefore not
be explained by differences in method sensitivity. Also derivati-
zation cannot explain the differences in results, because both
derivatized methods (HPLC-FLD and LC-MS/MS analysis of
derivatized samples) varied in their outcome. It has been suggested
that (underivatized) HILIC LC-MS/MS analysis is less suitable for
BMAA detection than LC-MS/MS analysis after derivatization
[24], but our study does not support this hypothesis as under-
ivatized LC-MS/MS analysis was in our case more precise and
more sensitive for samples than derivatized LC-MS/MS analysis
(Table 2). Furthermore, the warning that the signal of methionine
methylsulphonium might interfere with that of BMAA in under-
ivatized LC-MS/MS analysis [31] is unnecessary, because this
compound has a different molecular weight than BMAA and its
signal will therefore not be picked up in MRM analysis. We
conclude that the most likely cause of the differences in our
experiment is that HPLC-FLD has misidentified another amino
containing compound as BMAA in some samples and conse-
quently has overestimated BMAA concentrations in these samples.
From our study, it cannot be determined which compound has
mistakenly been identified as BMAA by HPLC-FLD analysis.
While attempts have been made to exclude compounds from being
possibly interfering in various methods of BMAA analysis [24,31],
these studies only focus on a few compounds, mostly diamino
acids. The possible similarity of the fragmentation pattern of
diamino acids with that of BMAA makes these compounds likely
candidates for interference with mass spectrometry analyses. The
compounds tested in these two studies did not interfere with the
BMAA signal in most tested methods, only one compound co-
eluted in an UHPLC-UV/MS method [31]. However, the list of
possible interfering compounds in HPLC-FLD analysis is much
larger and also includes compounds with only one amino group.
These two studies can therefore not be used to identify possibly
interfering compounds in previously performed HPLC-FLD
analyses. Furthermore, different chromatographic conditions can
result in different interfering compounds, which means that the
compound that has mistakenly been identified in our study, can be
another compound than the one that has interfered in other
studies.
The average BMAA concentrations found by HPLC-FLD in
this study are lower than concentrations found in free living
cyanobacteria by previous studies that used HPLC-FLD for
quantification [11,13] (Table 1). Furthermore, in our study BMAA
was identified in only three of the eight tested cyanobacterial
samples, while the other HPLC-FLD studies report presence of
BMAA in nearly all tested cyanobacteria. Again, this is most likely
due to the differences in chromatographic conditions between the
studies. Although presence of BMAA has been confirmed by LC-
MS/MS in the early HPLC-FLD based studies, BMAA concen-
trations determined by these LC-MS/MS analyses have not been
reported [11,13]. It is therefore unknown whether the concentra-
tions found by HPLC-FLD matched the concentrations found by
LC-MS/MS in these studies. Also in the only other study, so far,
that compared different analytical methods, BMAA concentra-
tions based on LC-MS(/MS) analyses were not reported [32].
Certainly, variations in BMAA concentrations found in different
studies may not only be caused by the use of different analytical
methods. BMAA concentrations may also differ as a result of the
origin or growth conditions of the cyanobacteria, which is the case
for most other cyanobacterial toxins [33]. An attempt has been
made to determine conditions under which cyanobacteria produce
BMAA [34], but much work is still needed to understand BMAA
production. Origin and growth conditions cannot explain the
incongruity observed in our study because we analyzed the same
material with different analytical methods. So, although the high
BMAA concentrations measured in the early studies may indeed
have resulted from samples that contained high amounts of
BMAA, it is more plausible that they are an artifact of the HPLC-
FLD method. Our results suggest that BMAA is not present in
high concentrations in cyanobacteria. Presence of lower concen-
trations of BMAA (low mg/g DW or ng/g DW) in (some)
cyanobacteria is more likely and could also explain why BMAA is
detected by some selective methods with high sensitivity [14,15]
and is not detected [17–19] or detected only in a number of
samples [23] by studies that have a lower sensitivity.
Our study only focused on three analytical methods and can
therefore not explain other discrepancies in published BMAA
concentrations than those between HPLC-FLD and (derivatized
or underivatized) LC-MS/MS analysis. More work is for instance
needed to explain the differences in concentrations found in
cyanobacterial field isolates from similar regions and grown under
similar condition that were analyzed by the same group by GC-
MS and LC-MS [16,22]. Also the high concentrations found by
CE analysis [21] are interesting, even though the authors of this
last manuscript acknowledge that the selectivity of their method is
low. In general, comparison of the quantitative results of different
studies is hampered by the absence of recovery and validation data
in many publications.
Even if BMAA concentrations in cyanobacteria are low, BMAA
can still pose a threat to human health. First, BMAA has the ability
to accumulate in food chains. In the Baltic sea, BMAA
concentrations in zooplankton, shellfish and bottom-dwelling fish
Table 3. Recovery (%) of extraction and hydrolysis, analyzed
by the three different methods.
Extraction Hydrolysis
average SD n average SD n
HPLC-FLD 86.8 10.1 12 46.7 8.5 12
LC-MS/MS derivatizeda 83.6 5.5 12 68.6 6.8 11
LC-MS/MS underivatizeda 85.5 5.9 12 69.3 4.2 12
arecovery is calculated for D3BMAA.
doi:10.1371/journal.pone.0036667.t003
Method Comparison for Cyanobacterial BMAA Analysis
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36667
species are up to 200 fold higher than in the local cyanobacteria
[14]. Moreover, laboratory studies have shown that the zooplank-
ton species Daphnia magna is able to take up BMAA from its
surrounding medium, thereby bioconcentrating BMAA up to
3800 times [35]. Presence of BMAA in the aquatic food chain
means that people are not only exposed to BMAA by direct
contact with cyanobacteria, but also through food. Exposure
through food may extent over a larger area and a larger period of
time than exposure through cyanobacteria. The dose of BMAA
obtained through food might therefore exceed the dose obtained
directly through cyanobacteria. Second, in addition to its own
neurotoxicity, BMAA can also enhance the effect of other
neurotoxins [36]. The additive effect of BMAA with other
cyanobacterial neurotoxins has not been evaluated yet, but BMAA
sometimes occurs simultaneously with the neurotoxins DAB [23],
anatoxin-a and saxitoxin [13] and synergistic toxicity cannot on
forehand be excluded.
We conclude that in our study HPLC-FLD overestimated
BMAA concentrations in some cyanobacterial samples due to its
low selectivity. Cyanobacterial BMAA concentrations seem to be
overestimated in some previous studies as well and are more likely
to be in the low mg/g DW or even in the ng/g DW range than in
the high mg/g DW range as sometimes reported. We therefore
recommend to only use selective and sensitive analytical methods
like LC-MS/MS for BMAA analysis. Although possibly present in
low concentrations in cyanobacteria, presence of BMAA in the
aquatic food chain and possible synergistic effects with other
cyanobacterial neurotoxins still urge for investigation on the risk of
BMAA for human health.
Materials and Methods
Eight cyanobacterial samples (four scum samples from the field
and four laboratory strains), a negative control (a green alga) and a
positive control (sarcotesta of a cycad seed) were prepared for
analysis of free and total BMAA. The sample treatments were the
ones that are most often applied: trichloroacetic acid extraction for
analysis of free BMAA and acid hydrolysis for total BMAA. All
sample treatments were performed in nine fold. Six replicates of
each fraction were then derivatized using AccQH-Tag and
analyzed by HPLC-FLD (n = 3) or LC-MS/MS (n = 3). The other
three replicates were analyzed by LC-MS/MS without derivati-
zation. Prior to extraction or hydrolysis, deuterium labeled BMAA
was added to the samples that were analyzed by LC-MS/MS as an
internal standard. L-2-aminobutyric acid (AAbA) was added after
extraction or hydrolysis to the samples that were analyzed by
HPLC-FLD and was used as retention time reference. Validation
of all methods was based on FDA guidelines [37,38].
Sample material
The control samples consisted of the green alga Scenedesmus
obliquus SAG 276/3a (negative control) and the sarcotesta of a
Cycas micronesica (Hill) seed (positive control). S. obliquus was
cultured as in [35] and was harvested directly before sample
preparation. The cycad seed was kindly provided by Chad Husby,
Montgomery Botanical Centre, Miami, US and was stored at
220uC after picking. The cyanobacterial scum samples were
collected in various lakes in The Netherlands in 2008 and 2009
and were dominated by either Anabaena, Planktothrix rubescens,
Figure 1. Chromatograms of the three analytical methods showing calibration standards and an extracted cyanobacterial sample.
Panels A–C show calibration standards, panels D–F show the extracted Anabaena field scum. The green line in panel D represents the unspiked
cyanobacterial sample, the blue line indicates the same sample, but spiked with BMAA before extraction. Colored lines in panels B and E represent
the transitions of ions with a mass-to-charge ratio (m/z) of 459 to m/z 171 (blue), 119 (green), 145 (pink) and 315 (orange). Colored lines in panels C
and F represent the transitions of m/z 119.1 to m/z 102.1 (blue), 88 (pink), 76 (green), 101 (gray) and 74 (orange). Transitions for D3BMAA are not
shown.
doi:10.1371/journal.pone.0036667.g001
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Aphanizomenon or Microcystis. The cyanobacterial laboratory strains
used were Cylindrospermopsis raciborskii CS-1, Aphanizomenon flos-aquae
CCAP 1401/7, Anabaena flos-aquae CCAP 1409/2A and Microcystis
aeruginosa NIVA CYA 228/1. The first three strains were grown in
batch cultures on a modified WC medium [39] at room
temperature at normal daylight and were harvested after a growth
period of 20 to 25 days, while Microcystis was grown for 15 days at
20uC and in 45 mmol quanta m22 s21 light in a 16:8 h light:dark
rhythm. All samples were lyophilized and stored at 220uC until
preparation.
Sample preparation
All lyophilized samples were homogenized and extracted or
hydrolyzed. 5 mg of sample (0.5 mg for the cycad seed) was
extracted for free BMAA at room temperature in the dark for two
hours in 300 ml 0.1 N trichloroacetic acid (TCA). After the
extraction, the sample was centrifuged and the supernatant was
transferred. 300 ml 0.1 N TCA was then again added to the pellet
and after vortexing and centrifugation the supernatant was pooled
with the first supernatant and lyophilized. The dried supernatants
were derivatized after dissolving them in 500 ml hot 20 mM HCl.
Samples were derivatized by adding 60 ml buffer and 20 ml reagent
(6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, purchased
as AccQH-Tag, Waters) to 20 ml sample [26]. Dried supernatants
for underivatized LC-MS/MS analysis were dissolved in 500 ml
65% acetonitrile, 35% Millipore water and 0.1% formic acid
(v:v:v).
For total BMAA, 1 mg of lyophilized sample (0.5 mg for the
cycad seed) was hydrolyzed in an hydrolysis/derivatization
workstation (Eldex), using 6 N HCl liquid hydrolysis for 20 hours
at 105uC in the absence of oxygen. After hydrolysis, samples for
derivatized analysis were dissolved in 500 ml hot 20 mM HCl and
subsequently diluted ten times in 20 mM HCl to obtain a protein
concentration below 0.1 g/l ([26,27], maximum protein content of
cyanobacteria was estimated to be 50%). Derivatization procedure
was the same as for the free fraction. Hydrolyzed samples for
underivatized LC-MS/MS analysis were dissolved in 1 ml 65%
acetonitrile, 35% Millipore water and 0.1% formic acid (v:v:v).
Deuterium labeled BMAA (D3BMAA, kindly provided by
Johan Rose´n, National Food Administration, Uppsala, Sweden
and synthesized as in [18]) was added to the samples that were
analyzed by LC-MS/MS prior to extraction or hydrolysis so the
maximum concentration at the moment of analysis was 400 mg/l.
L-2-aminobutyric acid (AAbA, Sigma-Aldrich) was added to the
samples that were analyzed by HPLC-FLD after extraction or
hydrolysis at a maximum concentration of 500 mg/l.
Sample analysis
HPLC-FLD analysis was performed on an Agilent 1100 LC-
FLD. Compounds were separated on a Nova-Pak C18
3.96300 mm, 4 mm column (Waters). Eluent A consisted of
140 mM sodium acetate and 5.6 mM triethylamine in Millipore
water, adjusted to pH 5.2 with phosphoric acid. Eluent B was
acetonitrile and eluent C was Millipore water. The elution
program was: 0 min 100% A; 7 min 90% A and 5.2% B; 10–
20 min 84% A and 8.3% B; 23 min 75% A and 13% B; 38 min
65% A and 18.2% B; 40 min 40% A and 31.2% B; 42.5–52 min
52% B and 48% C; 55–65 min 100% A. Flow rate was 1 ml/min,
injection volume 4 ml and column temperature 37uC. Excitation
wavelength was 250 nm, emission wavelength was 395 nm.
LC-MS/MS analysis of the derivatized samples was performed
on an Agilent 1200 LC and an Agilent 6401A QQQ. Compounds
were separated on a Zorbax Eclipse AAA 4.6675 mm, 3.5 mm
column (Agilent) with mobile phases acetonitrile with 0.1% formic
acid (v:v, eluent A) and Millipore water with 0.1% formic acid (v:v,
eluent B). The following gradient was applied: 0 min 1% A; 4 min
2% A; 8 min 5% A; 18 min 10% A; 20–24 min 50% A; 24–
38 min 0% A. Flow rate was 1 ml/min, injection volume 10 ml
and column temperature 40uC. The LC-MS/MS was operated in
positive mode with an ESI source, fragmentor voltage was 140 V.
Nitrogen was used as the drying and collision gas. Quadrupole 1
was operated in unit mode and quadrupole 2 was operated in
widest mode. BMAA was detected by the transitions mass-to-
Table 4. Free and total BMAA concentrations (mg/g DW, average and SD, n = 3) in control and cyanobacterial samples as analyzed
by three different methods.
HPLC-FLD LC-MS/MS derivatized LC-MS/MS underivatized
Free Total Free Total Free Total
Controls
S. obliquus SAG 276/3a (neg) n.d. n.d. n.d. n.d. n.d. n.d.
Cycad seed sarcotesta (pos) 18.2 (1.4) d. 8.8 (3.0) 104.9 (4.5) 10.7 (2.9) 75.0 (10.8)
Field scums
Anabaena 21.7 (3.1) n.d. n.d. n.d. n.d. n.d.
P. rubescens 6.3 (0.8) n.d. n.d. n.d. n.d. n.d.
Aphanizomenon n.d. n.d. n.d. n.d. n.d. n.d.
Microcystis n.d. n.d. n.d. n.d. n.d. n.d.
Lab strains
C. raciborskii CS-1 n.d. n.d. n.d. n.d. n.d. n.d.
Aph. flos-aquae CCAP 1401/7 56.2a d. n.d. n.d. n.d. n.d.
An. flos-aquae CCAP 1409/2A n.d. n.d. n.d. n.d. n.d. n.d.
M. aeruginosa NIVA CYA 228/1 n.d. n.d. n.d. n.d. n.d. n.d.
n.d.: not detected, d.: detected but below limit of quantification,
an = 2.
doi:10.1371/journal.pone.0036667.t004
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charge ratio (m/z) 459 to m/z 171 at 32 V collision energy, m/z
119 and m/z 145 (both 16 V). Ratio of the peak area of qualifier
m/z 119 to the peak area of quantifier m/z 171 was 10%, ratio of
the qualifier m/z 145 to m/z 171 was 14%. DAB was detected by
the transitions m/z 459 to m/z 171 (28 V), m/z 145 and m/z 315
(both 12 V). Ratio of the qualifier m/z 145 to quantifier m/z 171
was 83% and ratio of the qualifier m/z 315 to m/z 171 was 8%.
D3BMAA was detected by the transitions m/z 462 to m/z 171
(32 V), m/z 145 and m/z 122 (both 16 V). Ratio of the qualifier m/
z 145 to quantifier m/z 171 was 13% and ratio of the qualifier m/z
122 to m/z 171 was 23%.
Underivatized samples were analyzed on the same LC-MS/MS
equipment and with the same mobile phases as the derivatized
samples. Compounds were separated on a 2.16150 mm, 5 mm
diameter ZICH-HILIC column (Sequant) with a Direct-Con-
nectTM Filter (Grace Alltech). Flow rate was 0.4 ml/min, injection
volume 5 ml and column temperature 40uC. The following
gradient was applied: 0–2 min 95% A; 4 min 65% A; 8–17 min
55% A; 17–23 min 95% A. Fragmentor voltage was 50 V and
both quadrupoles were operated in unit mode. BMAA was
detected by the transitions m/z 119.1 to m/z 102.1 (4 V), m/z 88
and m/z 76 (both 8 V). Ratio of both qualifiers m/z 88 and m/z 76
to quantifiers m/z 102.1 was 21%. DAB was detected by the
transitions m/z 119.1 to m/z 101 (4 V) and m/z 74 (8 V). Ratio of
the qualifier m/z 76 to quantifier m/z 101 was 23%. D3BMAA was
detected by the transitions m/z 122.1 to m/z 105.1 (4 V), m/z 88
and m/z 76 (both 8 V). Ratio of qualifier m/z 88 to quantifier m/z
105.1 was 22%, ratio of m/z 76 to m/z 105.1 was 37%.
Calibration standards for the derivatized samples were prepared
in 20 mM HCl and then derivatized, calibration standards for the
underivatized samples were prepared in 65% acetonitrile, 35%
Millipore water and 0.1% formic acid (v:v:v). Calibration
standards for LC-MS/MS analysis contained BMAA, DAB
(DAB Dihydrochloride, Sigma-Aldrich) and D3BMAA. Calibra-
tion standards for HPLC-FLD analysis contained BMAA, DAB,
methionine (DL-Methionine, Fluka) and AAbA. BMAA concen-
trations in LC-MS/MS samples were determined by correcting
the response of BMAA for the response of D3BMAA. BMAA
concentrations analyzed by HPLC-FLD were calculated against
the calibration curve and subsequently corrected for the recovery
(see method validation).
Method validation
To make comparison of the HPLC-FLD method with both LC-
MS/MS methods possible, validation of both LC-MS/MS
methods was performed without correction for the response of
D3BMAA.
Linearity was determined by injecting a range of calibration
standards in triplicate.
For both LC-MS/MS methods, limit of detection (LOD) in
calibration standards was determined as the lowest injected
concentration with a signal-to-noise (S/N) ratio of all product
ions of at least 3:1. Furthermore, the ratio of the qualifier ions to
the quantifier ion should be within a 20% relative range of the
expected value. Limit of quantification (LOQ) was defined as the
lowest injected concentration with a S/N ratio of the quantifier ion
of at least 10:1. Furthermore, the ratio of the qualifier ions to the
quantifier should again be within the accepted range, and the S/N
ratio of the qualifier ions should at least be 3:1. For HPLC-FLD
analysis, LOD in calibration standards was defined as the lowest
concentration of which the peak was clearly distinguishable from
the background signal. LOQ was defined as the lowest
concentration that was linear on the calibration curve. Detection
and quantitation limits in samples were defined in the same way as
for calibration standards. Limits in samples were determined by
spiking an Anabaena scum sample with different BMAA concen-
trations prior to extraction or hydrolysis.
Intraday precision of response and retention time was
determined by injecting the highest calibration standard
(1000 mg/l) in six fold. For interday precision, calibration
standards were injected again in six fold on a different day and
the variation of all twelve injections was considered. Inter workup
precision was determined by spiking an Anabaena scum sample in
six fold before extraction or hydrolysis with either D3BMAA (both
LC-MS/MS methods, 200 ng for free BMAA, 400 ng for
underivatized total BMAA and 2000 ng for derivatized total
BMAA) or BMAA (HPLC-FLD method, 750 ng for free BMAA
and 9950 ng for total BMAA). The same sample treatment was
repeated in six fold on another day and response was compared.
The inter workup samples were also used for calculation of
recovery, which is in this study defined as the percentage of the
original signal that was recovered after sample preparation and
analysis.
Since no reference material is available for BMAA, accuracy
was not tested. Instead, a positive control sample (cycad seed
sarcotesta) was included. The mass of cycad seed sarcotesta used
for extraction and hydrolysis was lower than for the cyanobacterial
samples, so the signal of the cycad seed would be close to the
detection limits of the methods. Furthermore, recovery of all
sample treatments was determined.
Supporting Information
Figure S1 LC-MS/MS BMAA calibration curves for
derivatized analysis and underivatized analysis, cor-
rected for D3BMAA. Panel A shows the calibration curve for
derivatized analysis, panel B for underivatized analysis. All
concentrations are injected in triplicate, except 5 and 10 mg/l in
panel A, these concentrations are injected once.
(TIF)
Figure S2 Limits of detection (LODs) for BMAA in
spiked Anabaena scum samples. Panel A and B show
HPLC-FLD signals, panel C and D show LC-MS/MS signals of
derivatized samples and panel E and F show LC-MS/MS signals
of underivatized samples. Panels C and E represent samples that
are spiked with BMAA before extraction, panels B, D and F
represent samples that are spiked before hydrolysis. No LOD
could be defined for BMAA in extracted samples for HPLC-FLD
analysis (see results in main text), panel A therefore shows an
unspiked extracted field sample of Planktothrix rubescens with a low
response at the retention time of BMAA (see also Table 4 in main
text). Colored lines in panels C and D represent the transitions of
ions with a mass-to-charge ratio (m/z) of 459 to m/z 171 (blue),
119 (green), 145 (pink) and 315 (orange). Colored lines in panels E
and F represent the transitions of m/z 119.1 to m/z 102.1 (blue),
88 (pink), 76 (green), 101 (gray) and 74 (orange). Transitions for
D3BMAA are not shown.
(TIF)
Figure S3 Concentrations of BMAA in spiked Anabaena
scum samples, analyzed by LC-MS/MS and corrected
for D3BMAA. Panel A shows extracted derivatized samples,
panel B shows hydrolyzed derivatized samples, panel C shows
extracted underivatized samples and hydrolyzed underivatized
samples are shown in panel D. All samples are spiked before
extraction or hydrolysis and are injected once.
(TIF)
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